Supported by

TAVI (Transcatheter aortic valve implantation)

Latest TAVI content in interventional cardiology - research, practice, and education

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1469 results

TAVI: Late-Breaking Trials and Innovations

27 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

TAVI: Late-Breaking Trials and Innovations

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

Rapid-fire abstracts: session 4

27 Nov 2022 – From PCR London Valves 2022

In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...

Rapid-fire abstracts: session 4

Rapid-fire abstracts: session 3

27 Nov 2022 – From PCR London Valves 2022

Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.

Rapid-fire abstracts: session 3

Rapid-fire abstracts: session 2

27 Nov 2022 – From PCR London Valves 2022

Take advantage of this PCR LV 2022 session to discover more abstracts and learn more about how to predict TAVI bicuspid aortic valve re-access, or right ventricle-pulmonary artery coupling in patients with severe aortic stenosis, among others.

Rapid-fire abstracts: session 2

TAVI is a mature procedure: implications for lifelong management of young and old patients

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about TAVI implications for lifelong management, to understand what is happening in the field of aortic valve intervention and to appreciate the evidence governing the application of this procedure in the lifetime journey of patients with aortic...

TAVI is a mature procedure: implications for lifelong management of young and old patients

Hot TAVI topics - Cerebral embolic protection

27 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...

Hot TAVI topics - Cerebral embolic protection

TAVI: new devices and procedural refinements

27 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to TAVI new devices and procedural refinements to learn more about Meril's Myval transcatheter heart valve, the newest EVOLUT-FX self-expanding supra-annular valve, the OctaAlign technique with the novel Myval octacor transcatheter heart valve, and more!

TAVI: new devices and procedural refinements

DurAVR THV: Impact of Novel Leaflet Design on Hemodynamics & Transvalvular Physiology – FIH Results

Follow this dialogue between Bernard Prendergast, Christopher Meduri and João Cavalcante where they reflect on the journey in relation to transcatheter aortic valve implantation over the last 20 years and advances that can take us to a very bright and optimistic future - recorded for PCR...

DurAVR THV: Impact of Novel Leaflet Design on Hemodynamics & Transvalvular Physiology – FIH Results

The unmet need in severe aortic regurgitation: are we ready for TAVI?

The prevalence of valvular heart disease increases with advanced age and unfortunately, in many patients, it’s underdiagnosed, especially aortic regurgitation. In this presentation recorded for PCR London Valves 2022, Tanja Rudolph raises the question: are we ready for TAVR in aortic regurgitation?

View more videos and course...

The unmet need in severe aortic regurgitation: are we ready for TAVI?

A patient with severe aortic stenosis – how should I treat concomitant coronary artery disease?

31 Oct 2022

Discover the replay of this PCR Webinar on the Road in Verona, Italy on aortic stenosis with D. Milasinovic, C. de Biase and F. Ribichini.

A patient with severe aortic stenosis – how should I treat concomitant coronary artery disease?

A patient undergoing TAVI - how should I achieve optimal coronary access?

31 Oct 2022

Our duo of hosts Dejan Milasinovic and Chiara de Biase visit the cathlab of Khaled Al-Shaibi, based in Jeddah, Saudi Arabia.

A patient undergoing TAVI- how should we achieve optimal coronary access?

Bicuspid prevalence in China

31 Oct 2022

Discover the replay of this PCR webinar on TAVI with M. Chen, J. Kempfert, J.Z. Junjie, Y. Tang and Y. Wang.

Bicuspid prevalence in China

TAVI patients’ Lifetime Management: the unspoken consequences of Permanent Pacemaker Implantation

31 Oct 2022

Watch the replay of this webinar on TAVI with J. Rodés-Cabau, F. Saia and M. Ziacchi

TAVI patients’ Lifetime Management: the unspoken consequences of Permanent Pacemaker Implantation

Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses

26 Oct 2022

Edoardo provides us with the cardiac surgeon's point of view!

The present trial aimed to clarify the hemodynamic results between balloon-expandable valve (BEV) (SAPIEN 3 ULTRA - Edwards) and self-expandable valve (SEV) (EVOLUT R/Pro/Pro+ - Medtronic) in case of dysfunctional small-sized surgical bio-prosthesis.

Edoardo Zancanaro

Reviewer

Edoardo Zancanaro
Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses

Porcelain aorta, calcified aortic valve, and calcified left main: what comes first, the valve or the artery?

08 Nov 2022

How would you treat this 76-year-old male patient with severe AS symptomatic for angina, sinus rhythm with RBBB, previous bilateral CEA, and total occlusion of both the left CCA and the subclavian?

Author

Flavio Luciano Ribichini
Petros Dardas

Author

Petros Dardas
Beatriz Vaquerizo

Author

Beatriz Vaquerizo
Porcelain aorta, calcified aortic valve, and calcified left main: what comes first, the valve or the artery?

Abstracts - Coronary interventions - Session 4

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Structural interventions - Session 7

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Structural interventions - Session 6

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Structural interventions - Session 9

07 Oct 2022 – From AICT-AsiaPCR 2022